Elocom (mometasone furoate) ointment 30 g.

Description

Elocom Mode of application
Apply Elokom® ointment with a thin layer on the affected skin once a day. The duration of treatment is determined by the severity, course of the disease and is determined individually.

The use of topical corticosteroids for children and on the face should be limited to the minimum amount compared to effective therapeutic regimens, while the duration of treatment should not exceed 5 days.

Elocom Children.

For children over 2 years of age, use the drug only as directed by a doctor.

Since the value of the ratio of surface area and body weight in children is greater than in adults, children are at greater risk of suppression of the function of the hypothalamic-pituitary-adrenal system and manifestations of Cushing’s syndrome with the use of any topical GCS, which grows when applied over an area of ​​more than 20% of the surface body.

It is recommended to use the smallest amount of GCS necessary to obtain a therapeutic effect, especially in children. The course of treatment should not exceed 5 days. Long-term treatment with GCS can delay the growth and development of the child.

The safety of using Elokom® in children for more than 6 weeks has not been studied.

There are only limited data on the treatment of children under 2 years of age.

Mometasone should not be used to treat diaper dermatitis.

The ointment should not be applied under occlusive dressings, unless directed by a doctor, and should not be applied to areas under diapers or panties that are impervious to moisture.

Elocom Contraindications
Elokom® is contraindicated in rosacea, acne vulgaris, skin atrophy, perioral dermatitis, perianal and genital itching, diaper rashes, bacterial (eg impetigo, pyoderma), viral (eg herpes simplex, herpes zoster and chickenpox, simple warts, genital warts) molluscum), parasitic and fungal (for example, candida or dermatophyte) infections, tuberculosis, syphilis or post-vaccination reactions. Elokom® should not be used on wounds or skin covered with ulcers. The drug is contraindicated in patients with hypersensitivity to any of the components of the drug or to other GCS.

Composition
Active substance: mometasone furoate;

1 g of ointment contains 1 mg mometasone furoate.

Excipients: hexylene glycol, purified water, diluted phosphoric acid, propylene glycol stearate, white wax, white soft paraffin.

Release form
Ointment.

Basic physical and chemical properties: white or almost white opaque ointment, without foreign inclusions.

Package.

Tubes of 15 g or 30 g No. 1 in a cardboard box.

Storage conditions
Keep out of the reach of children at a temperature not exceeding 25 ºС.